These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18852137)

  • 1. Identification and characterization of small-molecule inhibitors of hepsin.
    Chevillet JR; Park GJ; Bedalov A; Simon JA; Vasioukhin VI
    Mol Cancer Ther; 2008 Oct; 7(10):3343-51. PubMed ID: 18852137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
    Franco FM; Jones DE; Harris PK; Han Z; Wildman SA; Jarvis CM; Janetka JW
    Bioorg Med Chem; 2015 May; 23(10):2328-43. PubMed ID: 25882520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of dipeptide-based hepsin inhibitors with Arg bioisosteres.
    Kwon H; Ha H; Jeon H; Jang J; Son SH; Lee K; Park SK; Byun Y
    Bioorg Chem; 2021 Feb; 107():104521. PubMed ID: 33334587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design, synthesis, and biological evaluation of Leu-Arg dipeptide analogs as novel hepsin inhibitors.
    Kwon H; Kim Y; Park K; Choi SA; Son SH; Byun Y
    Bioorg Med Chem Lett; 2016 Jan; 26(2):310-314. PubMed ID: 26711145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression.
    Tripathi M; Nandana S; Yamashita H; Ganesan R; Kirchhofer D; Quaranta V
    J Biol Chem; 2008 Nov; 283(45):30576-84. PubMed ID: 18784072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
    Xuan JA; Schneider D; Toy P; Lin R; Newton A; Zhu Y; Finster S; Vogel D; Mintzer B; Dinter H; Light D; Parry R; Polokoff M; Whitlow M; Wu Q; Parry G
    Cancer Res; 2006 Apr; 66(7):3611-9. PubMed ID: 16585186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of dye-conjugated hepsin inhibitors.
    Kim K; Kwon H; Choi D; Lim T; Minn I; Son SH; Byun Y
    Bioorg Chem; 2019 Aug; 89():102990. PubMed ID: 31136899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances of Hepsin-Targeted Inhibitors.
    Kwon H; Han J; Lee KY; Son SH; Byun Y
    Curr Med Chem; 2017; 24(21):2294-2311. PubMed ID: 28245763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Testing of Potent, Selective Hepsin Inhibitors via Application of an Automated Closed-Loop Optimization Platform.
    Pant SM; Mukonoweshuro A; Desai B; Ramjee MK; Selway CN; Tarver GJ; Wright AG; Birchall K; Chapman TM; Tervonen TA; Klefström J
    J Med Chem; 2018 May; 61(10):4335-4347. PubMed ID: 29701962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
    Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
    Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel mPGES-1 inhibitors through screening of a chemical library.
    Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors.
    Goswami R; Wohlfahrt G; Törmäkangas O; Moilanen A; Lakshminarasimhan A; Nagaraj J; Arumugam KN; Mukherjee S; Chacko AR; Krishnamurthy NR; Jaleel M; Palakurthy RK; Samiulla DS; Ramachandra M
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5309-14. PubMed ID: 26421993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology.
    Damalanka VC; Han Z; Karmakar P; O'Donoghue AJ; La Greca F; Kim T; Pant SM; Helander J; Klefström J; Craik CS; Janetka JW
    J Med Chem; 2019 Jan; 62(2):480-490. PubMed ID: 30571119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis.
    Tang X; Mahajan SS; Nguyen LT; Béliveau F; Leduc R; Simon JA; Vasioukhin V
    Oncotarget; 2014 Mar; 5(5):1352-62. PubMed ID: 24657880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.
    Li W; Wang BE; Moran P; Lipari T; Ganesan R; Corpuz R; Ludlam MJ; Gogineni A; Koeppen H; Bunting S; Gao WQ; Kirchhofer D
    Cancer Res; 2009 Nov; 69(21):8395-402. PubMed ID: 19843851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer.
    Lu L; Cole A; Huang D; Wang Q; Guo Z; Yang W; Lu J
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric antibody inhibition of human hepsin protease.
    Koschubs T; Dengl S; Dürr H; Kaluza K; Georges G; Hartl C; Jennewein S; Lanzendörfer M; Auer J; Stern A; Huang KS; Packman K; Gubler U; Kostrewa D; Ries S; Hansen S; Kohnert U; Cramer P; Mundigl O
    Biochem J; 2012 Mar; 442(3):483-94. PubMed ID: 22132769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic activation of pro-macrophage-stimulating protein by hepsin.
    Ganesan R; Kolumam GA; Lin SJ; Xie MH; Santell L; Wu TD; Lazarus RA; Chaudhuri A; Kirchhofer D
    Mol Cancer Res; 2011 Sep; 9(9):1175-86. PubMed ID: 21875933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepsin and prostate cancer.
    Wu Q; Parry G
    Front Biosci; 2007 Sep; 12():5052-9. PubMed ID: 17569629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers.
    Herter S; Piper DE; Aaron W; Gabriele T; Cutler G; Cao P; Bhatt AS; Choe Y; Craik CS; Walker N; Meininger D; Hoey T; Austin RJ
    Biochem J; 2005 Aug; 390(Pt 1):125-36. PubMed ID: 15839837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.